Obsessive-compulsive symptoms in schizophrenia: Neuropsychological perspectives

Psychiatric Annals

Volumn 29, Issue 9, 1999, Pages 525-528

  Berman, Ileana ^a,b,c   Chang, Howard H ^a,b   Klegon, David A ^a,b  

^a Southeastern Area ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Taunton State Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033435575     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19990901-09     Document Type: Review

References (28)

1. Stengel E. A study of some clinical aspects of the relationship between obsessional neurosis and psychotic reaction types. Journal of Mental Science, 1945;91:166-187.
2. Rosen I. The clinical significance of obsessions in schizophrenia. Journal of Mental Science. 1957;103:773-785.
3. Birnie WA, Litman SK. Obsessionality in schizophrenia. Canadian Psychiatric Association Journal. 1978;23:77-81.
4. Fenton WS, McGlashan TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986;143:437-441.
5. Berman I, Kalinowski A, Berman SM, Lengua J, Green AI. Obsessive and compulsive symptoms in chronic schizophrenia. Compr Psychiatry. 1995;36:6-10.
6. Samuel J, Nesdadt G, Walyniec P, Adler L, Liong KY, Pulver AE. Obsessive-compulsive symptoms in schizophrenia. Schizophr Res. 1993;9:139.
7. Bermanzohn P, Siris S. Comorbidity in schizophrenia. Presented at the annual meeting of the American Psychiatric Association; Miami, Florida; May 1995.
8. Insel TR, Akiskal HS. Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis. Am J Psychiatry. 1986;143:1527-1533.
9. Berman I, Merson A, Viegner B, Losonczy MF, Pappas D, Green AI. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J Nerv Ment Dis. 1998;186:150-156.
10. Berman I, Sapers BL, Chang HHJ, Losonczy MF, Schmilder J, Green AI. Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine. J Clin Psychopharmacol. 1995;15:206-210.
11. Baker RW, Chengappa KNR, Baird JW, Steingard S, Christ MAG, Schooler NR. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry. 1992;53:439-442.
12. LaPorta LD. More on obsessive-compulsive symptoms and clozapine. J Clin Psychiatry. 1994;55:312. Letter.
13. Patil VJ. Development of transient obsessive-compulsive symptoms during treatment with clozapine. Am J Psychiatry. 1992;149:272. Letter.
14. Keefe RSE. The contribution of neuropsychology to psychiatry. Am J Psychiatry. 1995;152:6-15.
15. Head D, Bolton D, Hymas N. Deficit in cognitive shifting ability in patients with obsessive-compulsive disorders. Biol Psychiatry. 1989;25:929-937.
16. Aronowitz B, Hollander E, DeCaria C, et al. Neuropsychology of obsessive-compulsive disorder: preliminary findings. Neuropsychiatry Neuropsychol Behav Neurol. 1994;7:81-86.
17. Christensen KJ, Kim SW, Dysken MW, Hoover KM. Neuropsychological performance in obsessive-compulsive disorder. Biol Psychiatry. 1992;31:4-18.
18. Cohen LJ, Hollander E, DeCaria CM, et al. Specificity of neuropsychological impairment in obsessive-compulsive disorder: a comparison with social phobic and normal control subjects. J Neuropsychiatry Clin Neurosci. 1996;8:82-85.
19. Goldberg TE, Gold J. Neurocognitive functioning in patients with schizophrenia. In: Bloom F, Kupfer D, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995:1245-1257.
20. Breese GR, Baumeister AA, McCown TJ, et al. Behavioral differences between neonatal and adult 6-hydroxy-dopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J Pharmacol Exp Ther. 1984;231:343-354.
21. Jackson D, Bruno JP, Stachowiak MK, et al. Inhibition of striatal acetylcholine release by serotonin and dopamine after the intracerebral administration of 6-hydroxydopamine to neonatal rats. Brain Res. 1988;457:267-273.
22. Davila R. Plasma HVA, neuroleptics, dopaminergic plasticity. Biol Psychiatry. 1989;25:1-3.
23. Davidson M, Kahn RS, Knott P, et al. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Arch Gen Psychiatry. 1991;48:910-913.
24. Barr LC, Goodman VVK, Price LH, McDougle CJ, Charney DS. The serotonin hypothesis of obsessive compulsive disorder: implication of pharmacologic challenge studies. J Clin Psychiatry. 1992;53(suppl):17-28.
25. Insel TR, Mueller EA, Alterman I, Linnoila M, Murphy DL. Obsessive-compulsive disorder and serotonin: is there a connection? Biol Psychiatry. 1985;20:1174-1188.
26. Hollander E, DeCaria CM, Nitescu A, et al. Serotonergic function in obsessive-compulsive disorder: behavioral neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry. 1992;49:21-28.
27. Bleich A, Brown SL, Kahn R, van Praag HM. The role of serotonin in schizophrenia. Schizophr Bull. 1988;14:297-315.
28. McDougle C, Goodman WK, Leckman JF, Price LH. The psychopharmacology of obsessive compulsive disorder. Psychiatr Clin North Am. 1993;16:749-766.